FDA targets two clinics marketing unapproved stem cell therapies 

May 11, 2018 , CNN Health
The US Food and Drug Administration filed two federal complaints Wednesday seeking to permanently ban two clinics from marketing stem cell products without regulatory approval and accusing them of "significant deviations" from good manufacturing practice requirements. 

Read the full story...

Trending healthcare news keywords at this moment

brain high walgreens treatment women drugs community blood tied risk kids diabetes heart disease trump plan drug study finds business people fda generic digital medical steps patients ceo year healthcare state court medicaid work care rural role therapy launches tips good cancer gene therapies end due human marketing pain obesity drinking tip summer opioid addiction family mental marijuana takes law highlights house play data immigrant parents stop hospital program young uk cannabis companies ' users case deaths amazon administration insurance plans severe system children improve gawande